News

FDA evaluating the use of oral fluconazole in pregnancy


 

References

The Food and Drug Administration is reviewing the results of a Danish study that concludes there is a possible increased risk of miscarriage with the use of oral fluconazole (Diflucan) in pregnancy, according to a safety alert issued April 26.

The current drug label for oral fluconazole states that data from studies in women does not suggest an increased risk of problems during pregnancy or abnormalities in developing babies when women used a single 150-mg dose to treat vaginal yeast infections. However, reports of abnormalities at birth have resulted from high doses (400-800 mg/day) taken during pregnancy for much longer than a single dose. The Danish study had most pregnant women use one or two doses of 150 mg.

Oral fluconazole is used to treat yeast infections of the vaginal area, mouth, and esophagus. It can also be used to treat a fungal infection of the brain and spinal cord.

The FDA is also evaluating additional data and will make recommendations when the review is complete.

“Until FDA’s review is complete and more is understood about this study and other available data, FDA advises cautious prescribing of oral fluconazole in pregnancy,” the safety alert states.

The FDA also noted that the Centers for Disease Control and Prevention recommends using topical antifungal products only when treating pregnant women with vulvovaginal yeast infections.

Read more about the investigation on the FDA website.

llaubach@frontlinemedcom.com

Recommended Reading

New Zika case study fills some research gaps
MDedge Family Medicine
CDC urges states to prepare for Zika
MDedge Family Medicine
Fetal malformation risk not increased after exposure to lamotrigine
MDedge Family Medicine
LMWH doesn’t reduce late pregnancy loss in women with thrombophilias
MDedge Family Medicine
HHS calls on Congress to approve supplemental Zika funding
MDedge Family Medicine
Intracranial calcification, hypomyelination seen with Zika virus congenital microcephaly
MDedge Family Medicine
Early predictors of GDM identified in women with PCOS
MDedge Family Medicine
Women with epilepsy conceive at normal rate
MDedge Family Medicine
Thousands of DNA modifications seen in infants of smoking mothers
MDedge Family Medicine
CDC issues guidance on worker precautions against Zika virus
MDedge Family Medicine